Platinum Investment Management’s Immunogen Inc IMGN Stock Holding History

Platinum Investment Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-90,600	Closed	-$242K	–	77
2016 Q3	$242K	Hold	90,600	–	–	0.01%	76
2016 Q2	$279K	Hold	90,600	–	–	0.01%	73
2016 Q1	$771K	Hold	90,600	–	–	0.02%	74
2015 Q4	$1.23M	Hold	90,600	–	–	0.03%	67
2015 Q3	$869K	Hold	90,600	–	–	0.02%	68
2015 Q2	$1.3M	Hold	90,600	–	–	0.03%	62
2015 Q1	$810K	Hold	90,600	–	–	0.02%	84
2014 Q4	$552K	Hold	90,600	–	–	0.01%	90
2014 Q3	$959K	Hold	90,600	–	–	0.02%	82
2014 Q2	$1.07M	Buy	90,600 +17,000	+23%	+$213K	0.02%	80
2014 Q1	$1.1M	Hold	73,600	–	–	0.02%	77
2013 Q4	$1.08M	Hold	73,600	–	–	0.02%	70
2013 Q3	$1.25M	Hold	73,600	–	–	0.02%	66
2013 Q2	$1.22M	Buy	+73,600	New	+$1.19M	0.02%	56

Other funds holding IMGN

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Platinum Investment Management's IMGN Position: Q4 2016 in Review

Platinum Investment Management sold out of Immunogen Inc (IMGN) in Q4 2016, closing a stake of 90,600 shares — an estimated $242K sold.

Platinum Investment Management first reported a position in IMGN in Q2 2013 and held it in 14 quarters. The position peaked at $1.3M in Q2 2015. 156 funds tracked by Wall St. Rank hold IMGN as of Q4 2016.

Platinum Investment Management reported no remaining Immunogen Inc position as of Q4 2016 after selling out during the quarter.
Platinum Investment Management sold 90,600 Immunogen Inc shares in Q4 2016, an estimated $242K.
Platinum Investment Management first reported a position in Immunogen Inc in Q2 2013 and held it in 14 quarters.
Platinum Investment Management's Immunogen Inc position peaked at $1.3M in Q2 2015.
156 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2016.

Based on Platinum Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.